Executive director, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
Kevin Outterson is a professor of law at Boston University and director of CARB-X, the largest public-private partnership in the world for pre-clinical antibiotic R&D, funding $450M in research projects globally to protect us from drug-resistant bacteria.
Sessions as a Speaker
G3) Antibiotic Resistance: The Next Challenges
28 October 2017
3:15 pm – 4:30 pm
- Marriott Marquis: Salons 4-6